At Prostate Cancer Research we are constantly on the look out for the latest developments in the prostate cancer space – whether that is new drugs, new surgical devices, or whatever that might be – which can make outcomes for patients better. In Scanning the Horizon we present some of the newest advances and research which, if everything continues to go well, could be more widely available to patients in the next few years. Of course nothing is certain and there are risks some or all of these could not make it for one reason or another but we will continue to bring you the latest advances and developments to keep you up to date and informed as best we can.

Scanning The Horizon

A first of its kind new drug - CCS1477

A new miniature surgical probe - SENSEI®

A new drug for advanced prostate cancer - ipatasertib

The latest advancements in tackling certain hereditary cancers - PARP inhibitors

A new drug for metastatic castrate resistant prostate cancer - cabozantinib